$6.37
-0.57-8.21%
Pre-Market: Mar 26, 5:25 PM EDT
NeueHealth reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NeueHealth using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
NEUE | NeueHealth | -$2.31 | -$4.18 | — | — | $245.09M | $270.10M | — | — | 05/07/2025 | Get Alert |
NEUE | NeueHealth | $19.54 | -$3.99 | -$7.41 | -85.71% | $292.87M | $261.80M | $232.64M | -11.14% | 03/20/2025 | Get Alert |
NEUE | NeueHealth | -$72.52 | -$3.10 | -$6.78 | -118.71% | $269.40M | $234.89M | $232.93M | -0.83% | 11/07/2024 | Get Alert |
NEUE | NeueHealth | -$8.55 | -$3.26 | -$6.42 | -96.93% | $297.98M | $252.48M | $225.99M | -10.49% | 08/07/2024 | Get Alert |
NEUE | NeueHealth | -$9.04 | -$5.30 | -$2.31 | 56.42% | $300.55M | $248.51M | $245.09M | -1.37% | 05/08/2024 | Get Alert |
NEUE | NeueHealth | -$13.64 | -$4.16 | $19.54 | 569.71% | $227.70M | $283.44M | $292.87M | 3.33% | 03/06/2024 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-20 | $-7.41 | $-3.99 | -85.7 % |
Q3 | 2024-11-07 | $-6.78 | $-3.10 | -118.7 % |
Q2 | 2024-08-07 | $-6.42 | $-3.26 | -96.9 % |
Q1 | 2024-05-08 | $-2.31 | $-5.30 | 56.4 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-20 | $232.64M | $261.80M | -11.1 % |
Q3 | 2024-11-07 | $232.93M | $234.89M | -0.83 % |
Q2 | 2024-08-07 | $225.99M | $252.48M | -10.5 % |
Q1 | 2024-05-08 | $245.10M | $248.51M | -1.37 % |
NeueHealth (NEUE) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on March 20, 2025 for Q4.
The Actual EPS was $-7.41, which missed the estimate of $-3.99.
The Actual Revenue was $232.6M, which missed the estimate of $261.8M.
Browse earnings estimates, EPS, and revenue on all stocks.